Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Wulff

Showing results (101-110 of 222) with videos related to

Pageof 23
Sort By:
Molecular Pharmacology|March 11, 2025
6,7-Dichloro-1H-indole-2,3-dione-3-oxime functions as a superagonist for the intermediate-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel K<sub>Ca</sub>3.1Joshua A Nasburg, Kyle C Rouen, Connor J Dietrich, et al.
Cancers|March 1, 2019
Radiation Increases Functional KCa3.1 Expression and Invasiveness in GlioblastomaGiuseppina D'Alessandro, Lucia Monaco, Luigi Catacuzzeno, et al.
Plos One|January 7, 2014
The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosisKaty M Roach, Katy Morgan Roach, Stephen Mark Duffy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2015
Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicityLee-Way Jin, Makoto Horiuchi, Heike Wulff, et al.
Glia|October 4, 2016
Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microgliaHai M Nguyen, Eva M Grössinger, Makoto Horiuchi, et al.
Kidney International|June 13, 2008
KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney diseaseMamdouh Albaqumi, Shekhar Srivastava, Zhai Li, et al.
Molecular Pharmacology|March 3, 2011
Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: pharmacological evidence of deep-pore gating of K(Ca)2 channelsDavid Paul Jenkins, Dorte Strøbæk, Charlotte Hougaard, et al.
Cell Calcium|January 14, 2022
Channelopathy-causing mutations in the S<sub>45</sub>A/S<sub>45</sub>B and HA/HB helices of K<sub>Ca</sub>2.3 and K<sub>Ca</sub>3.1 channels alter their apparent Ca<sup>2+</sup> sensitivityRazan Orfali, Young-Woo Nam, Hai Minh Nguyen, et al.
Vascular Pharmacology|August 5, 2015
A pharmacologic activator of endothelial KCa channels increases systemic conductance and reduces arterial pressure in an anesthetized pig modelRamesh C Mishra, Jamie R Mitchell, Carol Gibbons-Kroeker, et al.
Archives of Toxicology|March 13, 2023
Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) causes seizure activity in larval zebrafish via antagonism of γ-aminobutyric acid type A receptor α1β2γ2Paige C Mundy, Alicia Werner, Latika Singh, et al.
Pageof 23

Showing results (101-110 of 222) with videos related to

Sort By:
Pageof 23
Molecular Pharmacology|March 11, 2025
6,7-Dichloro-1H-indole-2,3-dione-3-oxime functions as a superagonist for the intermediate-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel K<sub>Ca</sub>3.1Joshua A Nasburg, Kyle C Rouen, Connor J Dietrich, et al.
Cancers|March 1, 2019
Radiation Increases Functional KCa3.1 Expression and Invasiveness in GlioblastomaGiuseppina D'Alessandro, Lucia Monaco, Luigi Catacuzzeno, et al.
Plos One|January 7, 2014
The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosisKaty M Roach, Katy Morgan Roach, Stephen Mark Duffy, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2015
Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicityLee-Way Jin, Makoto Horiuchi, Heike Wulff, et al.
Glia|October 4, 2016
Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microgliaHai M Nguyen, Eva M Grössinger, Makoto Horiuchi, et al.
Kidney International|June 13, 2008
KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney diseaseMamdouh Albaqumi, Shekhar Srivastava, Zhai Li, et al.
Molecular Pharmacology|March 3, 2011
Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: pharmacological evidence of deep-pore gating of K(Ca)2 channelsDavid Paul Jenkins, Dorte Strøbæk, Charlotte Hougaard, et al.
Cell Calcium|January 14, 2022
Channelopathy-causing mutations in the S<sub>45</sub>A/S<sub>45</sub>B and HA/HB helices of K<sub>Ca</sub>2.3 and K<sub>Ca</sub>3.1 channels alter their apparent Ca<sup>2+</sup> sensitivityRazan Orfali, Young-Woo Nam, Hai Minh Nguyen, et al.
Vascular Pharmacology|August 5, 2015
A pharmacologic activator of endothelial KCa channels increases systemic conductance and reduces arterial pressure in an anesthetized pig modelRamesh C Mishra, Jamie R Mitchell, Carol Gibbons-Kroeker, et al.
Archives of Toxicology|March 13, 2023
Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) causes seizure activity in larval zebrafish via antagonism of γ-aminobutyric acid type A receptor α1β2γ2Paige C Mundy, Alicia Werner, Latika Singh, et al.
Pageof 23